Ads
related to: renal cell carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- How This Treatment Works
Search results
Multiphase comparative study for WHO/ISUP nuclear grading diagnostic model based on enhanced CT...
Nature· 3 hours agoTo compare and analyze the diagnostic value of different enhancement stages in distinguishing low and high nuclear grade clear cell renal cell ...
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL)
GuruFocus.com via Yahoo Finance· 3 days agoThe company is known for its product Cabometyx, which is used in the treatment of various forms of...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 4 days agoNotable data include an oral presentation on biomarker analyses from the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial (NCT02811861), which evaluated lenvatinib (LENVIMA®), the orally ...
Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla
Zacks· 6 days agoFree Report) entered into a settlement agreement with Cipla, which was looking to market a generic...
Nimbus reports positive data from Phase I/II solid tumour therapy trial
Clinical Trials Arena via Yahoo Finance· 3 days agoAccording to the results, 16.7% of response-evaluable patients experienced clinical benefits from...
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at...
WKBN 27 Youngstown· 4 days agoOn May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal
Kidney Cancer Immunotherapy Response Linked to Signature Reflecting HLA, Tumor Immune Activity
GenomeWeb News· 6 days agoResearchers found an immune checkpoint blockade response signature in renal cell carcinoma that reflects tumor immune activity influenced by human leukocyte antigen features.
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoThe company also has other high-impact clinical programs in later stages of development which are intended to treat conditions like renal cell ...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 4 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 5 days agoPer BMY, this is the first phase III study of the subcutaneous formulation of nivolumab to evaluate...
Ads
related to: renal cell carcinoma
